Johnson & Johnson
(JNJ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 14,714,000 | 15,119,000 | 15,297,000 | 1,300,000 | 16,540,000 |
| Depreciation Amortization | 7,231,000 | 7,009,000 | 6,929,000 | 5,642,000 | 3,754,000 |
| Income taxes - deferred | -1,141,000 | -2,476,000 | -1,016,000 | 2,406,000 | -341,000 |
| Accounts receivable | 837,000 | -309,000 | -1,216,000 | -616,000 | -1,076,000 |
| Other Working Capital | 2,753,000 | 3,845,000 | -28,000 | 11,258,000 | -1,784,000 |
| Other Operating Activity | -858,000 | 228,000 | 2,235,000 | 1,066,000 | 1,674,000 |
| Operating Cash Flow | $23,536,000 | $23,416,000 | $22,201,000 | $21,056,000 | $18,767,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,042,000 | -233,000 | -467,000 | -1,447,000 | -1,959,000 |
| Net Acquisitions | -7,323,000 | -5,810,000 | -899,000 | -35,151,000 | -4,509,000 |
| Purchase Of Investment | -21,089,000 | -3,920,000 | -5,626,000 | -6,153,000 | -33,950,000 |
| Sale Of Investment | 12,137,000 | 3,387,000 | 4,289,000 | 28,117,000 | 35,780,000 |
| Other Investing Activity | -1,508,000 | 382,000 | -464,000 | -234,000 | -123,000 |
| Investing Cash Flow | $-20,825,000 | $-6,194,000 | $-3,167,000 | $-14,868,000 | $-4,761,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 3,391,000 | 39,000 | 80,000 | 869,000 | 111,000 |
| Debt Issued | 7,431,000 | 3,000 | 5,000 | 8,992,000 | 12,004,000 |
| Debt Repayment | -1,064,000 | -2,823,000 | -1,555,000 | -1,777,000 | -2,223,000 |
| Common Stock Issued | 1,114,000 | 954,000 | 949,000 | 1,062,000 | 1,189,000 |
| Common Stock Repurchased | -3,221,000 | -6,746,000 | -5,868,000 | -6,358,000 | -8,979,000 |
| Dividend Paid | -10,481,000 | -9,917,000 | -9,494,000 | -8,943,000 | -8,621,000 |
| Other Financing Activity | -3,290,000 | 475,000 | -2,627,000 | -1,518,000 | -2,032,000 |
| Financing Cash Flow | $-6,120,000 | $-18,015,000 | $-18,510,000 | $-7,673,000 | $-8,551,000 |
| Exchange Rate Effect | 89,000 | -9,000 | -241,000 | 337,000 | -215,000 |
| Beginning Cash Position | 17,305,000 | 18,107,000 | 17,824,000 | 18,972,000 | 13,732,000 |
| End Cash Position | 13,985,000 | 17,305,000 | 18,107,000 | 17,824,000 | 18,972,000 |
| Net Cash Flow | $-3,320,000 | $-802,000 | $283,000 | $-1,148,000 | $5,240,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 23,536,000 | 23,416,000 | 22,201,000 | 21,056,000 | 18,767,000 |
| Capital Expenditure | -3,347,000 | -3,498,000 | -3,670,000 | -3,279,000 | -3,226,000 |
| Free Cash Flow | 20,189,000 | 19,918,000 | 18,531,000 | 17,777,000 | 15,541,000 |